Quasar Medical, a global company in the manufacturing of interventional and minimally invasive medical devices, has announced the opening of its newest manufacturing facility in Chonburi, Thailand, marking a ‘key milestone’ in the company’s ongoing global growth and providing scalable solutions to customers worldwide.
The new facility is Quasar’s third site in the country, and one that strengthens the company’s regional manufacturing presence in Asia and improves its capacity to support both global and local ‘in-region, for-region’ production strategies. Designed to support high-volume manufacturing and complex device assembly, the new facility offers advanced capabilities in catheter systems, micro-assembly, and finished device production.
Alex Wallstein, Quasar Medical’s CEO, said: “Opening our new facility in Thailand reflects our commitment to scaling alongside our customers and investing in regions that enable long-term growth. This expansion strengthens our ability to deliver high-quality, complex medical devices at scale while enhancing supply chain flexibility. Thailand’s strong manufacturing ecosystem and skilled workforce make it an ideal location to support the next phase of our global growth.”
By the end of 2026, the Thailand operation is projected to have about 1,200 staff members across manufacturing, engineering, quality, and operations. With a growing network of global facilities and over 4,500 employees across Asia, North America, and Europe, Quasar provides fully integrated solutions spanning design, prototyping, and scalable manufacturing, enabling ‘cost-effective production and unmatched speed-to-market’.